Projekt

SAKK 24/14: Anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative EGFR positive breast cancer – A multicenter single arm phase II trial

Automatisch geschlossen · 2016 bis 2023

RSS